We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Genomic Classifier Test for Lung Disease Validated

By LabMedica International staff writers
Posted on 18 Apr 2019
Print article
Image: The Envisia Genomic Classifier Kit improves diagnosis for patients undergoing evaluation for interstitial lung diseases (ILDs), including idiopathic pulmonary fibrosis (IPF) (Photo courtesy of Veracyte).
Image: The Envisia Genomic Classifier Kit improves diagnosis for patients undergoing evaluation for interstitial lung diseases (ILDs), including idiopathic pulmonary fibrosis (IPF) (Photo courtesy of Veracyte).
In the appropriate clinical setting, the diagnosis of idiopathic pulmonary fibrosis (IPF) requires a pattern of usual interstitial pneumonia to be present on high-resolution chest computerized tomography (HRCT) scan or surgical lung biopsy.

In cases where a CT scan is inconclusive, diagnosis is often achieved by a surgical lung biopsy, which can cause complications. A correct diagnosis is important because patients diagnosed with interstitial lung disease that is not IPF are often treated with immunosuppressants, which can be harmful if that patient does in fact have IPF.

A large team of scientists working with the University of Washington Medical Center (Seattle, WA, USA) prospectively recruited 237 patients for this study from those enrolled in the Bronchial Sample Collection for a Novel Genomic Test (BRAVE) study in 29 US and European sites. Histopathological diagnoses were made by experienced pathologists. Three to five transbronchial lung biopsy samples were collected from all patients specifically for this study, pooled by patient, and extracted for transcriptomic sequencing.

After exclusions, diagnostic histopathology and RNA sequence data from 90 patients were used to train a machine-learning algorithm to identify a usual interstitial pneumonia pattern. The primary study endpoint was validation of the classifier in 49 patients by comparison with diagnostic histopathology. To assess clinical utility, they compared the agreement and confidence level of diagnosis made by central multidisciplinary teams based on anonymized clinical information and radiology results plus either molecular classifier or histopathology results.

Overall, for the 94 patients analyzed, the two teams agreed 86% of the time. For 46 patients, in which histopathology was diagnostic, the teams reported being confident in their diagnosis for 29 cases when just using histopathology to diagnose and 22 cases when using Envisia, a statistically insignificant difference. In 48 patients for whom histopathology did not yield a diagnosis or a classifiable result, the teams reported making confident diagnoses in 30 cases using Envisia and 20 using histopathology results.

The authors concluded that the molecular test provided an objective method to aid clinicians and multidisciplinary teams in ascertaining a diagnosis of IPF, particularly for patients without a clear radiological diagnosis, in samples that can be obtained by a less invasive method. Further prospective clinical validation and utility studies are planned. The study was published on April 1, 2019, in the journal Lancet Respiratory Medicine.

Related Links:
University of Washington Medical Center

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.